 NEW YORK and LONDON, Feb. 05, 2021 GLOBE NEWSWIRE -- Tiziana Life Sciences plc NASDAQ: TLSA LSE: TILS Tiziana or the Company, a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announces the appointment of Dr. Thomas Adams, Ph.D. as an executive director. 